- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02408133
Effectiveness of Home-based Exercise in Quality of Life and Physical Fitness in Older Woman in Breast Cancer Treatment
September 28, 2016 updated by: José Roberto da Silva Junior, Professor Fernando Figueira Integral Medicine Institute
Effectiveness of Home-based Exercise in Quality of Life and Physical Fitness in Older Woman in Breast Cancer Treatment: Randomized Clinical Trial
The purpose of this study is to evaluate the effectiveness of home exercise on quality of life and physical fitness of elderly women with breast cancer patients undergoing cancer treatment.
Study Overview
Detailed Description
Cancer has excelled as a leading cause of mortality.
It is particularly serious in the elderly due to increased risk of functional impairment and present comorbidities.
The physical exercise appears as a promising intervention in the various stages of the treatment, mitigating the adverse effects in short- and long-term the oncologic treatment.
Its regular practice after a diagnosis of breast cancer is associated with 40 % to 50 % lower rates of mortality.
Produces metabolic and morphological changes that may make it an important option in the treatment, prevention, and recovery process of these patients.
In this context the present study aims to verify the effectiveness of home exercise on quality of life and physical fitness of elderly undergoing treatment for breast cancer.
This study it's a Randomized Clinical Trial.
Data will be collected at the Department of Oncology at the Professor Fernando Figueira Integral Medicine Institute (IMIP), which serves patients in the public health system (SUS) from the metropolitan area of Recife, State of Pernambuco.
will be held from March to December 2015.
Will be studied elderly diagnosed with breast cancer undergoing treatment in the Adult Oncology Service of IMIP.
For the analysis of means and frequencies, the investigators intend to use descriptive statistics and the results will be displayed in graphs and tables.
For inferential statistical analysis, the investigators intend to use the Student's t test, or the Mann - Whitney test, according to the normality of the sample.
For categorical variables, contingency tables are constructed of type 2x2.
Chi-square tests of association with Yates correction and Fisher's exact test will be used.
The risk ratio (RR) will be calculated as a measure of the relative risk of different outcomes according to the realization of one or another approach to exercise and control group.
The Software Stata 12.0 will be used for data processing and will be accepted at p < 0,05.
The project meets the requirements of the National Board of Health and was approved by the IMIP Research Ethics Committee.
Patients who agree to sign the Instrument of Consent will be included in the study.
Study Type
Interventional
Enrollment (Actual)
75
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
60 years to 74 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Breast cancer diagnosis with stage I or II;
- Being in treatment for breast cancer (chemotherapy; radiotherapy and / or hormone therapy).
Exclusion Criteria:
- Absolute contraindication for physical exercises;
- Severe depression diagnosis using the Geriatric Depression Scale;
- Malnutrition (wasting grades I, II and III), detected by body mass index (BMI), according to the WHO criteria.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Control
The control group will be accompanied according to the service routine.
|
|
|
Experimental: Exercise
The group will be instructed to perform home exercises autonomously for range of motion and muscular fitness
|
Will be offered to the group, instructional material (manual exercises) and point you to an exercise routine to be performed independently for range of motion and muscular fitness, using the environmental resources of the same household.
A daily frequency in performing this exercise routine is suggested.
Also, be given incentives and guidelines for the practice of active commuting (walking) to be accumulated at least 10 to 20 minutes of this activity daily.
All control guidelines and training for the use of the exercise manual will be offered through an introductory lecture and subsequent weekly telephone contacts (2 times a week).
The participants in this group should fulfill their respective program for a total period of 12 weeks.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Variation in the performance of Lift and Sitting Test
Time Frame: Change from Baseline in Lift and Sitting Test and after 12 weeks
|
Test which comprises the Battery Senior Fitness Test (SFT).
Evaluates the Lower body strength according to the number of times the individual stood up and sat down in 30 seconds.
Characterized as continuous numeric variable.
|
Change from Baseline in Lift and Sitting Test and after 12 weeks
|
|
Variation in the performance of Flexion forearm Test
Time Frame: Change from Baseline in Flexion forearm Test and after 12 weeks
|
Test which comprises the Battery Senior Fitness Test (SFT).
Evaluates the upper body strength according to the number of push-ups of forearm in 30 seconds.
Characterized as continuous numeric variable.
|
Change from Baseline in Flexion forearm Test and after 12 weeks
|
|
Variation in the performance of Six Minute Walk Test (6MWT)
Time Frame: Change from Baseline in Six Minute Walk Test (6MWT) and after 12 weeks
|
Test which comprises the Battery Senior Fitness Test (SFT).
Evaluates aerobic endurance.
Total meters walked for 6 minutes walk.
Characterized as continuous numeric variable.
|
Change from Baseline in Six Minute Walk Test (6MWT) and after 12 weeks
|
|
Variation in the performance of March Stationary two minutes Test
Time Frame: Change from Baseline in March Stationary two minutes Test and after 12 weeks
|
Test which comprises the Battery Senior Fitness Test (SFT).
Evaluates aerobic endurance (alternative test).
Total double past stationary in 2 minutes.
Characterized as continuous numeric variable.
|
Change from Baseline in March Stationary two minutes Test and after 12 weeks
|
|
Variation in the performance of Skip and Vir 2.44 meters test
Time Frame: Change from Baseline in Skip and Vir 2.44 meters test and after 12 weeks
|
Test which comprises the Battery Senior Fitness Test (SFT).
Assesses motor agility and dynamic balance.
Evaluates the time in seconds and hundredths in an established path of 2.44 meters on the route to go and return to starting position.
Characterized as continuous numerical variable.
|
Change from Baseline in Skip and Vir 2.44 meters test and after 12 weeks
|
|
Variation in the performance of Sit and Reach Modified test (In the Chair)
Time Frame: Change from Baseline in Sit and Reach Modified test (In the Chair) and after 12 weeks
|
Test which comprises the Battery Senior Fitness Test (SFT).
Evaluates the lower hemisphere flexibility.
distance in centimeters reached the tip of the middle fingers and the floor in the sitting position.
Characterized as continuous numerical variable.
|
Change from Baseline in Sit and Reach Modified test (In the Chair) and after 12 weeks
|
|
Variation in the performance of Flexibility test of the upper limbs
Time Frame: Change from Baseline in Flexibility test of the upper limbs and after 12 weeks
|
Test which comprises the Battery Senior Fitness Test (SFT).
Evaluates the flexibility of the upper limbs.
It measures the distance in centimeters between the tips of the fingers in the back area.
Characterized as continuous numeric variable.
|
Change from Baseline in Flexibility test of the upper limbs and after 12 weeks
|
|
Body Mass Index
Time Frame: Change from Baseline in Body Mass Index and after 12 weeks
|
the calculation will be determined by the ratio between the weight (in kilograms) and the square of height (in meters).
Characterized as continuous numeric variable
|
Change from Baseline in Body Mass Index and after 12 weeks
|
|
Variation in the performance of Muscle strength Test
Time Frame: Change from Baseline in Muscle strength Test after 12 weeks
|
Hand Grip Strength Test.
Continuous numeric variable: average kilogram-force (KgF)
|
Change from Baseline in Muscle strength Test after 12 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Quality of life
Time Frame: Change from Baseline in Quality of life after 12 weeks
|
Numeric variable: average score from 0 to 100 for 30 issues of questionnaire developed by the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30)
|
Change from Baseline in Quality of life after 12 weeks
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Weight
Time Frame: Change from Baseline in Weight after 12 weeks
|
Measurement of body mass, using electronic scale Tanita®.
Characterized as continuous numerical variable, measured in kilograms
|
Change from Baseline in Weight after 12 weeks
|
|
Height
Time Frame: Change from Baseline in Height after 12 weeks
|
Greater distance between the vertex and the ground when the individual in the standing position, using the stadiometer Sanny® brand.
Characterized as continuous numeric variable measured in meters
|
Change from Baseline in Height after 12 weeks
|
|
Total Muscle Mass Index (IMMT)
Time Frame: Change from Baseline in Total Muscle Mass Index (IMMT) after 12 weeks
|
Measure of muscle mass relative amount contained in the body, through perimetry using anthropometric tape Sanny® brand.
Characterized as continuous numeric variable.
|
Change from Baseline in Total Muscle Mass Index (IMMT) after 12 weeks
|
|
Fat percentage
Time Frame: Change from Baseline in Fat percentage after 12 weeks
|
as the relative amount of fat contained in the body by means of perimetry using anthropometric Sanny® tape mark.
Characterized as continuous numeric variable.
|
Change from Baseline in Fat percentage after 12 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Study Director: João Guilherme Bezerra Alves, Doctor, Instituto de Medicina Integral Prof. Fernando Figueira
- Principal Investigator: Breno Augusto Bormann de Souza Filho, Graduate, Instituto de Medicina Integral Prof. Fernando Figueira
- Study Director: José Roberto da Silva Junior, Master, Instituto de Medicina Integral Prof. Fernando Figueira
- Study Director: William Serrano Smethurst, Master, Instituto de Medicina Integral Prof. Fernando Figueira
- Study Director: JuremaTelles de Oliveira Lima, Master, Instituto de Medicina Integral Prof. Fernando Figueira
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2016
Primary Completion (Actual)
February 1, 2016
Study Completion (Actual)
February 1, 2016
Study Registration Dates
First Submitted
February 24, 2015
First Submitted That Met QC Criteria
March 31, 2015
First Posted (Estimate)
April 3, 2015
Study Record Updates
Last Update Posted (Estimate)
September 30, 2016
Last Update Submitted That Met QC Criteria
September 28, 2016
Last Verified
September 1, 2016
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- U1111-1165-5043
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Breast Cancer
-
Baylor Breast Care CenterRecruitingBreast Cancer | Breast Neoplasm | Triple Negative Breast Cancer | Triple Negative Breast Neoplasms | HER2-positive Breast Cancer | Breast Cancer Stage II | Breast Cancer Female | Breast Cancer Stage III | Estrogen Receptor-positive Breast Cancer | Hormone Receptor-positive Breast Cancer | Breast Cancer InvasiveUnited States
-
Innocrin PharmaceuticalCompletedBreast Cancer | Advanced Breast Cancer | Metastatic Breast Cancer | Triple Negative Breast Cancer | Male Breast Cancer | ER+ Breast Cancer | Cancer of the BreastUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedInflammatory Breast Cancer | Male Breast Cancer | Stage IV Breast Cancer | Stage IIIB Breast Cancer | Estrogen Receptor-negative Breast Cancer | Estrogen Receptor-positive Breast Cancer | Progesterone Receptor-negative Breast Cancer | Progesterone Receptor-positive Breast CancerUnited States
-
University of Colorado, DenverCompletedStage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast CancerUnited States
-
Northwestern UniversityEisai Inc.UnknownMale Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative...United States
-
National Cancer Institute (NCI)TerminatedMale Breast Cancer | Stage IV Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative Breast CancerCanada
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyActive, not recruitingStage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative Breast CancerUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)TerminatedMale Breast Cancer | Stage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast CancerUnited States
-
Mayo ClinicMarker Therapeutics, Inc.CompletedHER2-positive Breast Cancer | Male Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast CancerUnited States
-
University of Central FloridaFlorida Department of HealthRecruitingBreast Cancer | Breast Cancer Female | Breast Cancer Diagnosis | Breast Cancer Survivors | Breast Cancer Detection | Breast Cancer AwarenessUnited States
Clinical Trials on Home exercise
-
Fenerbahce UniversityCompleted
-
Northwestern Health Sciences UniversityHealth Resources and Services Administration (HRSA); Berman Center for Outcomes...Completed
-
Northwestern Health Sciences UniversityHealth Resources and Services Administration (HRSA); Berman Center for Outcomes...Completed
-
Joshua SubialkaCompleted
-
Ümmahani KuşCompletedKnee Osteoarthritis (Knee OA)Turkey
-
The Miriam HospitalNational Heart, Lung, and Blood Institute (NHLBI)CompletedPhysical ActivityUnited States
-
Mike O'Callaghan Military HospitalCompletedInsertional Achilles TendinopathyUnited States
-
Suleyman Demirel UniversityRecruiting
-
Kafrelsheikh UniversityRecruitingLow Back Pain | Pilates Exercises | Nonspecific | Postnatal WomenEgypt
-
Northwestern Health Sciences UniversityDepartment of Health and Human ServicesCompletedSub-acute and Chronic Back-related Leg PainUnited States